These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis. McCormack PL Drugs; 2012 Mar; 72(5):585-617. PubMed ID: 22397329 [TBL] [Abstract][Full Text] [Related]
7. Tranexamic acid inhibits fibrinolysis, shortens the bleeding time and improves platelet function in patients with chronic renal failure. Mezzano D; Panes O; Muñoz B; Pais E; Tagle R; González F; Mezzano S; Barriga F; Pereira J Thromb Haemost; 1999 Oct; 82(4):1250-4. PubMed ID: 10544908 [TBL] [Abstract][Full Text] [Related]
8. Desmoteplase-mediated plasminogen activation and clot lysis are inhibited by the lysine analogue tranexamic acid. Niego B; Horvath A; Coughlin PB; Pugsley MK; Medcalf RL Blood Coagul Fibrinolysis; 2008 Jun; 19(4):322-4. PubMed ID: 18469556 [No Abstract] [Full Text] [Related]
9. Biological mechanisms and individual variation in fibrinolysis after major trauma. Coats TJ; Morsy M Emerg Med J; 2020 Mar; 37(3):135-140. PubMed ID: 32001608 [TBL] [Abstract][Full Text] [Related]
10. Clinical use of synthetic antifibrinolytic agents during liver transplantation. Kang Y Semin Thromb Hemost; 1993; 19(3):258-61. PubMed ID: 8362255 [No Abstract] [Full Text] [Related]
11. The effective concentration of tranexamic acid for inhibition of fibrinolysis in neonatal plasma in vitro. Yee BE; Wissler RN; Zanghi CN; Feng C; Eaton MP Anesth Analg; 2013 Oct; 117(4):767-772. PubMed ID: 24023015 [TBL] [Abstract][Full Text] [Related]
12. Hypofibrinolysis induced by tranexamic acid does not influence inflammation and mortality in a polymicrobial sepsis model. Campos Nogueira YA; Gomes da Costa LN; Levy CE; Orsi FA; de Lima F; Annichinno-Bizzacchi JM; De Paula EV PLoS One; 2019; 14(12):e0226871. PubMed ID: 31891611 [TBL] [Abstract][Full Text] [Related]
13. Tranexamic acid modulates the cellular immune profile after traumatic brain injury in mice without hyperfibrinolysis. Draxler DF; Daglas M; Fernando A; Hanafi G; McCutcheon F; Ho H; Galle A; Gregory J; Larsson P; Keragala C; Wright DK; Tavancheh E; Au AE; Niego B; Wilson K; Plebanski M; Sashindranath M; Medcalf RL J Thromb Haemost; 2019 Dec; 17(12):2174-2187. PubMed ID: 31393041 [TBL] [Abstract][Full Text] [Related]
14. Early tranexamic acid use in trauma haemorrhage: why do we give it and which patients benefit most? Cole E; Davenport R Int Emerg Nurs; 2015 Jan; 23(1):38-41. PubMed ID: 24776457 [No Abstract] [Full Text] [Related]
15. Tranexamic acid prolongs survival after controlled hemorrhage in rats. Roy M; Burggraf M; Lendemans S; de Groot H; Rohrig R J Surg Res; 2017 Feb; 208():104-110. PubMed ID: 27993197 [TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of tranexamic acid in pediatric trauma patients: Evidence from meta-analysis. Al-Jeabory M; Gasecka A; Wieczorek W; Mayer-Szary J; Jaguszewski MJ; Szarpak L Am J Emerg Med; 2021 Nov; 49():404-405. PubMed ID: 33722435 [No Abstract] [Full Text] [Related]
18. Anaphylaxis with associated fibrinolysis, reversed with tranexamic acid and demonstrated by thrombelastography. De Souza RL; Short T; Warman GR; Maclennan N; Young Y Anaesth Intensive Care; 2004 Aug; 32(4):580-7. PubMed ID: 15675222 [TBL] [Abstract][Full Text] [Related]